Electroacupuncture may reduce hot flashes among breast cancer survivors
the ONA take:
Electroacupuncture may be more effective and safer than gabapentin for managing hot flashes among breast cancer survivors, according to a new study published online ahead of print in the Journal of Clinical Oncology.
For the study, researchers from the University of Pennsylvania Perelman School of Medicine in Philadelphia, PA, and colleagues sought to compare the effects of electroacupuncture with gabapentin for hot flashes among breast cancer survivors.
Researchers enrolled 120 breast cancer survivors who were experiencing bothersome hot flashes at least twice per day day. Participants were randomly assigned to receive 8 weeks of electroacupuncture or gabapentin once daily with placebo acupuncture or pills.
Results showed that by week 8, patients in the electroacupuncture group experienced the greatest reduction in hot flash composite score, followed by placebo electroacupuncture, gabapentin, and placebo pills (P≤0.001).
In regard to safety, patients in the gabapentin group experienced the greatest amount of treatment-related adverse events, followed by placebo pills, electroacupuncture, and placebo electroacupuncture (P=0.005).
By week 24, electroacupuncture was still the most effective treatment for reducing hot flash composite score. The authors note that these findings need to be confirmed in a larger randomized controlled trial with long-term follow-up.
Electroacupuncture may be more effective and safer than gabapentin for managing hot flashes among breast cancer survivors.
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- In HER2+ Breast Cancer, Higher TIL Levels Associated With Improved OS
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Costs, Complications Higher for Women Who Undergo Second Surgery After BCS
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Fluorescent Nanoparticles Represent Novel Detection Method of HER2 Expression
- Assessment of Stromal Features in DCIS Requires Robustness
- Profile of Tivantinib and its Potential in the Treatment of Hepatocellular Carcinoma: the evidence to date
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|